392 PROTECT-1 Study Demonstrated Efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Treatment of Patients with Moderate to Severe Crohn's Disease

✍ Scribed by Satish Keshav; Daniel Johnson; Pirow Bekker; Thomas J. Schall

• Book ID: 119430152
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 123 KB
• Volume: 136
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/s0016-5085(09)60295-x